Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation

Business Wire Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FS Development Corp., which merged with Gemini Therapeutics, Inc. ("Gemini" or "the Company") (NASDAQ: GMTX) on February 5, 2021. Such investors who...\n more…